NO20082278L - Triazolderivater som inhibitorer av 11-beta-hydroksysteroid-dehydrogenase-1 - Google Patents
Triazolderivater som inhibitorer av 11-beta-hydroksysteroid-dehydrogenase-1Info
- Publication number
- NO20082278L NO20082278L NO20082278A NO20082278A NO20082278L NO 20082278 L NO20082278 L NO 20082278L NO 20082278 A NO20082278 A NO 20082278A NO 20082278 A NO20082278 A NO 20082278A NO 20082278 L NO20082278 L NO 20082278L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxysteroid dehydrogenase
- triazole derivatives
- inhibitors
- beta
- niddm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72872305P | 2005-10-20 | 2005-10-20 | |
PCT/US2006/040459 WO2007047625A2 (en) | 2005-10-20 | 2006-10-16 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082278L true NO20082278L (no) | 2008-07-17 |
Family
ID=37963190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082278A NO20082278L (no) | 2005-10-20 | 2008-05-19 | Triazolderivater som inhibitorer av 11-beta-hydroksysteroid-dehydrogenase-1 |
Country Status (18)
Country | Link |
---|---|
US (1) | US7981910B2 (pt) |
EP (1) | EP1940393B1 (pt) |
JP (1) | JP5036722B2 (pt) |
KR (1) | KR20080059236A (pt) |
CN (2) | CN101291672A (pt) |
AU (1) | AU2006304434B2 (pt) |
BR (1) | BRPI0617501A2 (pt) |
CA (1) | CA2625871C (pt) |
CR (1) | CR9931A (pt) |
EC (1) | ECSP088384A (pt) |
IL (1) | IL190436A0 (pt) |
MA (1) | MA30201B1 (pt) |
NI (1) | NI200800069A (pt) |
NO (1) | NO20082278L (pt) |
RU (1) | RU2008119842A (pt) |
SV (1) | SV2009002876A (pt) |
WO (1) | WO2007047625A2 (pt) |
ZA (1) | ZA200802104B (pt) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7834178B2 (en) | 2006-03-01 | 2010-11-16 | Bristol-Myers Squibb Company | Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors |
BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
EP2136803B1 (en) * | 2007-04-18 | 2012-05-02 | Merck Sharp & Dohme Corp. | Triazole derivatives which are smo antagonists |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
TW201014822A (en) | 2008-07-09 | 2010-04-16 | Sanofi Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
FR2942797B1 (fr) * | 2009-03-03 | 2011-04-29 | Pf Medicament | Derives de benzothiazines, leur preparation et leur application a titre de medicaments |
ES2350077B1 (es) | 2009-06-04 | 2011-11-04 | Laboratorios Salvat, S.A. | Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1. |
CN102482312A (zh) | 2009-08-26 | 2012-05-30 | 赛诺菲 | 新颖的杂芳族氟代糖苷结晶水合物、含有这些化合物的药物和它们的用途 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN104961696A (zh) * | 2015-07-13 | 2015-10-07 | 佛山市赛维斯医药科技有限公司 | 一类卤苯三氮唑亚砜类11β-HSD1抑制剂、制备方法及其用途 |
CN104987313A (zh) * | 2015-07-13 | 2015-10-21 | 佛山市赛维斯医药科技有限公司 | 一类末端取代的三氮唑亚砜类化合物、其制备方法及其用途 |
CN105001171A (zh) * | 2015-07-13 | 2015-10-28 | 佛山市赛维斯医药科技有限公司 | 一类硝基苯三氮唑亚砜类11β-HSD1抑制剂及其用途 |
CN104961697A (zh) * | 2015-07-13 | 2015-10-07 | 佛山市赛维斯医药科技有限公司 | 末端卤素取代的三氮唑亚砜类化合物、其制备方法及其用途 |
CN104910084A (zh) * | 2015-07-13 | 2015-09-16 | 佛山市赛维斯医药科技有限公司 | 末端胺基取代的三氮唑亚砜类化合物、其制备方法及其用途 |
CN105017170A (zh) * | 2015-07-13 | 2015-11-04 | 佛山市赛维斯医药科技有限公司 | 一类腈基苯三氮唑亚砜类11β-HSD1抑制剂及其用途 |
CN104910083A (zh) * | 2015-07-13 | 2015-09-16 | 佛山市赛维斯医药科技有限公司 | 烷氧苯基三氮唑亚砜类11β-HSD1抑制剂、制备方法及其用途 |
CN105001170A (zh) * | 2015-07-13 | 2015-10-28 | 佛山市赛维斯医药科技有限公司 | 末端腈基取代的三氮唑亚砜类化合物、其制备方法及其用途 |
CN104987312A (zh) * | 2015-07-13 | 2015-10-21 | 佛山市赛维斯医药科技有限公司 | 一类胺基苯三氮唑亚砜类11β-HSD1抑制剂及其用途 |
CN104974103A (zh) * | 2015-07-14 | 2015-10-14 | 佛山市赛维斯医药科技有限公司 | 一类含苯并异恶唑和烷氧苯基类结构的化合物及其用途 |
CN104926745A (zh) * | 2015-07-14 | 2015-09-23 | 佛山市赛维斯医药科技有限公司 | 含苯并异恶唑和末端卤代苄基类结构的化合物及其用途 |
CN105017135A (zh) * | 2015-07-19 | 2015-11-04 | 佛山市赛维斯医药科技有限公司 | 一类二吡啶叔醇结构的11β-HSD1抑制剂、制备方法及其用途 |
CN105001152A (zh) * | 2015-07-19 | 2015-10-28 | 佛山市赛维斯医药科技有限公司 | 一类二甲胺基二吡啶叔醇结构的11β-HSD1抑制剂及其用途 |
MX2020002944A (es) * | 2017-09-14 | 2020-09-28 | Daiichi Sankyo Co Ltd | Compuesto que tiene estructura ciclica. |
US11917514B2 (en) | 2018-08-14 | 2024-02-27 | Rapidsos, Inc. | Systems and methods for intelligently managing multimedia for emergency response |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2397B1 (en) * | 2002-12-20 | 2007-06-17 | ميرك شارب اند دوم كوربوريشن | Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors |
-
2006
- 2006-10-16 CN CNA2006800389598A patent/CN101291672A/zh active Pending
- 2006-10-16 KR KR1020087009369A patent/KR20080059236A/ko not_active Application Discontinuation
- 2006-10-16 AU AU2006304434A patent/AU2006304434B2/en not_active Ceased
- 2006-10-16 US US12/083,047 patent/US7981910B2/en active Active
- 2006-10-16 CN CN201410039746.3A patent/CN103724335A/zh active Pending
- 2006-10-16 JP JP2008536728A patent/JP5036722B2/ja not_active Expired - Fee Related
- 2006-10-16 WO PCT/US2006/040459 patent/WO2007047625A2/en active Application Filing
- 2006-10-16 CA CA2625871A patent/CA2625871C/en not_active Expired - Fee Related
- 2006-10-16 RU RU2008119842/04A patent/RU2008119842A/ru not_active Application Discontinuation
- 2006-10-16 NI NI200800069A patent/NI200800069A/es unknown
- 2006-10-16 BR BRPI0617501-5A patent/BRPI0617501A2/pt not_active IP Right Cessation
- 2006-10-16 EP EP06817031A patent/EP1940393B1/en active Active
-
2008
- 2008-03-06 ZA ZA200802104A patent/ZA200802104B/xx unknown
- 2008-03-25 IL IL190436A patent/IL190436A0/en unknown
- 2008-04-17 EC EC2008008384A patent/ECSP088384A/es unknown
- 2008-04-18 SV SV2008002876A patent/SV2009002876A/es not_active Application Discontinuation
- 2008-04-25 CR CR9931A patent/CR9931A/es unknown
- 2008-05-16 MA MA30932A patent/MA30201B1/fr unknown
- 2008-05-19 NO NO20082278A patent/NO20082278L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2009512704A (ja) | 2009-03-26 |
CR9931A (es) | 2008-08-21 |
WO2007047625A2 (en) | 2007-04-26 |
US7981910B2 (en) | 2011-07-19 |
MA30201B1 (fr) | 2009-02-02 |
CN103724335A (zh) | 2014-04-16 |
WO2007047625A3 (en) | 2007-10-11 |
BRPI0617501A2 (pt) | 2011-07-26 |
ECSP088384A (es) | 2008-05-30 |
CA2625871C (en) | 2014-07-08 |
CA2625871A1 (en) | 2007-04-26 |
NI200800069A (es) | 2008-06-25 |
AU2006304434B2 (en) | 2012-04-05 |
CN101291672A (zh) | 2008-10-22 |
ZA200802104B (en) | 2009-08-26 |
US20090258913A1 (en) | 2009-10-15 |
SV2009002876A (es) | 2009-02-19 |
JP5036722B2 (ja) | 2012-09-26 |
EP1940393B1 (en) | 2012-07-25 |
AU2006304434A1 (en) | 2007-04-26 |
EP1940393A4 (en) | 2008-12-17 |
EP1940393A2 (en) | 2008-07-09 |
RU2008119842A (ru) | 2009-12-10 |
IL190436A0 (en) | 2008-12-29 |
KR20080059236A (ko) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082278L (no) | Triazolderivater som inhibitorer av 11-beta-hydroksysteroid-dehydrogenase-1 | |
NO20053546L (no) | Triazolderivater som inhibitorer av 11-beta-hydroksysteroiddehydrogenase-1. | |
EP1797034A4 (en) | SULFONYL COMPOUNDS AS AN INHIBITORS OF 11-BETA-HYDROXYSTEROIDDEHYDROGENASE-1 | |
ATE476425T1 (de) | Triazolderivate als inhibitoren von 11-beta- hydroxysteroid-dehydrogenase-1 | |
WO2007087150A3 (en) | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | |
NO20050102L (no) | 11-beta-hydroksysteroid-dehydrogenase 1-inhibitorer som kan anvendes ved behandlingen av sukkersyke, overvekt og dyslipidemi | |
WO2005016877A3 (en) | Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | |
DK1711184T3 (da) | (3-Oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamid-derivater og beslægtede forbindelser som glycogenphosphorylaseinhibitorer til behandling af diabetes og fedme | |
NO20080010L (no) | GPCR-agonister | |
CY1110753T1 (el) | Αναστολεις της 11-βητα-υδροξυστεροειδους αφυδρογονασης i | |
NO20091734L (no) | Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse | |
EA201000561A1 (ru) | Производные пиридина, пригодные в качестве активаторов глюкокиназы | |
EA201000562A1 (ru) | Производные n-(пиразол-3-ил)бензамида в качестве активаторов глюкокиназы | |
NO20084307L (no) | Heterocykliske GPCR agonister | |
DK2035379T3 (da) | Inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1 | |
NO20084380L (no) | Neuromedin U-reseptoragonister og anvendelser derav | |
WO2007003961A3 (en) | Gpcr agonists | |
CL2007002890A1 (es) | Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad. | |
ATE555081T1 (de) | Adamantyl-derivate als inhibitoren des 11-beta- hydroxysteroid-dehydrogenase-1-enzyms | |
CL2008003847A1 (es) | Compuestos derivados de 6-fenilpirazin-2-carboxamida y 6-fenilpirazin-2-carbotioamida, inhibidores de dgat-1; composicion farmaceutica; y su uso en el tratamiento de la diabetes mellitus y obesidad. | |
NO20080052L (no) | G-Protein kopplede reseptoragonister | |
ATE557023T1 (de) | Piperidinylverbindungen als gpcr-agonisten | |
TW200716622A (en) | Substituted piperidines | |
NO20074049L (no) | Fremgangsmater for anvendelse av doble PPAR-agonistforbindelser, og legemiddelleveringsanordninger som inneholder slike forbindelser | |
DOP2003000795A (es) | Derivados de triazol como inhibidores de ii-beta- hidroxiesteroide deshidrogenasa-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |